UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000026173
Receipt No. R000030071
Scientific Title Early anti-VEGF Therapy Intervention for Retinal Vein Occlusion
Date of disclosure of the study information 2017/02/16
Last modified on 2020/02/19 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Early anti-VEGF Therapy Intervention for Retinal Vein Occlusion
Acronym Early anti-VEGF Therapy Intervention for RVO
Scientific Title Early anti-VEGF Therapy Intervention for Retinal Vein Occlusion
Scientific Title:Acronym Early anti-VEGF Therapy Intervention for RVO
Region
Japan

Condition
Condition Retinal vein occlusion
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To assess efficacy of early anti-VEGF intervention for retinal vein occlusion
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Phase IV

Assessment
Primary outcomes Mean change from baseline best corrected visual acuity and macular retinal sensitivity at month 12.
Key secondary outcomes Mean number of intravitreal injection at month 12.
Mean change from baseline central retinal thickness (CRT) at month 12.
Mean change from baseline best corrected visual acuity and macular retinal sensitivity at month 6.
ocular serious adverse event.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Symptomatic retinal vein occlusion with best corrected visual acuity of 20/40 or better, at least 3 months before enrollment.
Key exclusion criteria 1. prior laser treatment, surgery, local steroid injection or anti-VEGF drug administration
2. bilateral retinal vein occlusion
3. uncontrolled glaucoma
4. uncontrolled systemic hypertension
5. other retinal disorders
Target sample size 50

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Kentaro Kojima
Organization Kyoto Prefectural University of Medicine
Division name Ophthalmology
Zip code
Address 465 kajii-cho, Kamigyo-ku, Kyoto
TEL 075-251-5578
Email kenkojim@koto.kpu-m.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Kentaro Kojima
Organization Kyoto Prefectural University of Medicine
Division name Ophthalmology
Zip code
Address 465 kajii-cho, Kamigyo-ku, Kyoto
TEL 075-251-5578
Homepage URL
Email kenkojim@koto.kpu-m.ac.jp

Sponsor
Institute Kyoto Prefectural Univerisity of Medicine
Institute
Department

Funding Source
Organization Bayer
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 02 Month 16 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2016 Year 12 Month 01 Day
Date of IRB
2017 Year 02 Month 23 Day
Anticipated trial start date
2017 Year 02 Month 24 Day
Last follow-up date
2019 Year 10 Month 31 Day
Date of closure to data entry
2020 Year 01 Month 31 Day
Date trial data considered complete
2020 Year 02 Month 28 Day
Date analysis concluded
2020 Year 03 Month 31 Day

Other
Other related information none

Management information
Registered date
2017 Year 02 Month 16 Day
Last modified on
2020 Year 02 Month 19 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000030071